Trisomy 21 (T21) confers increased gene dosage of the amyloid precursor protein (APP) and other proteins (BACE2, S100β, DYRK1A, RCAN1) involved in Alzheimer's disease (AD) pathology. This evidence concerns the gene S100B and Alzheimer disease.